www.mirg.org
Mesothelioma - What is it?
Where Do I Go From Here?
Clinical Trials
Types of Mesothelioma
   >Pleural Mesothelioma
   >Peritoneal Mesothelioma
Mesothelioma clinical signs?
Mesothelioma Diagnosis
Choosing a Doctor
   >Doctor Worksheet
   >Clinical Trial Worksheet
Mesothelioma Treatments
Mesothelioma Lawyer
Mesothelioma Imagery
Mesothelioma Related
Occupations

Asbestos Cancer
Mesothelioma News
Mesothelioma News adobe .PDF



Mesothelioma Information and Resource Group on the symptoms, treatments and clinical signs

Mesothelioma Article Archives 1993-2002


Swedish study hints mesothelioma incidence might drop faster than expected.
December 2002

New Chemotherapy Promising for Asbestos Lung Cancer.
December 2002

INTERNATIONAL MESOTHELIOMA CONFERENCE SCHEDULED FOR DECEMBER IN AUSTRALIA.
December 2002

NEW STUDIES ON ALIMTA SHOW PROMISING RESULTS FOR MESOTHELIOMA VICTIMS.
November 1, 2002

Paul Sugarbaker Article on Treatments for Peritoneal Mesothelioma Patients.
October 2002

Association between simian virus 40 and non-Hodgkin lymphoma Regis A Vilchez, Charles R Madden, Claudia A Kozinetz, Steven J Halvorson, Zoe S White, Jeffrey L Jorgensen, Chris J Finch, Janet S Butel.
2002

Clinical and immunological assessment of Mycobacterium vaccae (SRL172) with chemotherapy in patients with malignant mesothelioma.
2002

Growing Incidence of Malignant Mesothelioma and Its Treatment To Be Addressed at International Investigators' Meeting: Germany, Italy, Israel and the Czech Republic Participating in Alfacell's MM Program.
Press Release from Alfacell, April 15, 2002

Orphan Drug Designation Granted for Treatment of Mesothelioma and Ovarian Cancer.
Press Release from NeoPharm, Inc., February 14, 2002

Study Shows SuperGen's Decitabine Corrects DNA Methylation, Key Mechanism of Cancer Growth: Data presented at 93rd Annual Meeting of AACR.
Press Release from SuperGen, April 11, 2002

Update on Phase III Program of ONCONASE ® for The Treatment of Patients with Unresectable Malignant Mesothelioma.
Press Release from Alfacell, April 3, 2002

New anti-cancer drug to be trialed on humans.
Report from ABC News, April 2002

Encouraging Survival in Patients With Advanced Malignant Mesothelioma Treated With Alfacell's ONCONASE ®.
Press Release from Alfacell, January 22, 2002

In the company of asbestos Magic mineral to killer dust: Turner & Newall and the asbestos hazard
Geoffrey Tweedale. Oxford: Oxford University Press, 2000.
Pp 334. £40·00. ISBN 0198296908.

Entremed, Inc. Releases Endostatin Phase I Study Data
November 9, 2000

Successful Immunochemotherapy for Patients with Malignant Mesothelioma: Report of Two Cases

Multimodality Management of Malignant Pleural Mesothelioma

Familial Pleural Malignant Mesothelioma: Clustering in Three Sisters and One Cousin

A Review of Dr. Sugarbaker's Results Using Tri-Modal Therapy on 183 Patients from 1980 to 1997

Pathology of Diffuse Malignant Pleural Mesothelioma

Current Therapy for Mesothelioma, Sugarbaker, et al, 1997

Primary Immunochemotherapy for Malignant Pleural Mesothelioma

Malignant Mesothelioma in Women

Abstracts found in various medical journals which address Treatment Options for Mesothelioma Patients (1991-1995):

Mesothelioma, current insights (1994)

Abstracts Found in Various Medical Journals Concerning Peritoneal Mesothelioma:




MIRG.org 1-888-802-6376 e-mail

www.MIRG.org Site Map About Us Contact Us Links Disclaimer

Mesothelioma Information Resource Group, MIRG.org, tries to assist individuals and families in learning about mesothelioma and other asbestos related injuries. It is the aim of MIRG.org to provide an account of the disease mesothelioma, its causes, various treatment options and potential legal impact. To find out more about Mesothelioma and other asbestos related diseases, new medical advances, and clinical trials now available please use the links provided.
The information on this website is presented by the Mesothelioma Information Resource Group and is for informational purposes only. No particular course of treatment is suggested. All persons are advised to consult with a medical doctor concerning treatment of mesothelioma or any illness. Also, nothing on this website is intended to constitute legal advice by a lawyer or attorney. Note disclaimer.